Home › Funds › SIG BROKERAGE, LP › GILD
SIG BROKERAGE, LP position in GILD
GILEAD SCIENCES INC · Health Care
SIG BROKERAGE, LP reported holding 64,235 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$9.6M, representing 0.56% of its reported portfolio and ranking #38 among its reported holdings. SIG BROKERAGE, LP has disclosed GILD holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How SIG BROKERAGE, LP's GILD position evolved
SIG BROKERAGE, LP first disclosed a stake in GILD in Q2 2025 at 54,513 shares (US$6.0M). The position peaked in Q3 2026 at 64,235 shares, worth US$9.6M. Across 6 filings, SIG BROKERAGE, LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 64,235 shares valued at US$9.6M — an increase of 11,426 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 54.51K | $6.04M | New |
| Q3 2025 | 52.08K | $5.78M | Reduce |
| Q4 2025 | 51.90K | $6.37M | Hold |
| Q1 2026 | 51.30K | $7.15M | Reduce |
| Q2 2026 | 52.81K | $6.67M | Add |
| Q3 2026 | 64.23K | $9.57M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- BlackRock Inc 125.25M sh · $18.67B · Q3 2026
- Fidelity Management & Research (FMR) 58.27M sh · $8.68B · Q3 2026
- Invesco Ltd 38.66M sh · $5.76B · Q3 2026
- Capital World Investors 35.93M sh · $5.36B · Q3 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 27.66M sh · $4.12B · Q3 2026
- Capital Research Global Investors 23.98M sh · $3.57B · Q3 2026
- DODGE & COX 21.80M sh · $3.25B · Q3 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- MFS Investment Management 11.46M sh · $1.77B · Q3 2026
- Amundi US 11.26M sh · $1.68B · Q3 2026
- Legal & General Investment Management America 10.40M sh · $1.55B · Q3 2026
More on SIG BROKERAGE, LP
FAQ
How long has SIG BROKERAGE, LP held GILD?
SIG BROKERAGE, LP has disclosed GILD holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is SIG BROKERAGE, LP's current position in GILD?
As of Q3 2026, SIG BROKERAGE, LP holds 64.23K shares of GILD (GILEAD SCIENCES INC), valued at $9.57M, representing 0.56% of its reported portfolio and ranking #38.
Has SIG BROKERAGE, LP been buying or selling GILD?
In the latest 13F filing (Q3 2026), SIG BROKERAGE, LP increased its position in GILD. The position peaked in Q3 2026 at 64.23K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.